Immunicon Corporation Announces FDA Clearance of the CellSearch(TM) Circulating Tumor |

« FDA Approvals - Sirion Therapeutics Receives NDA Acceptance And Priority Review From The | Main | FDA Proposes Guidance for Dissemination of Information on Unapproved Uses »

Immunicon Corporation Announces FDA Clearance of the CellSearch(TM) Circulating Tumor

Immunicon Corporation Announces FDA Clearance of the CellSearch(TM) Circulating Tumor Cell Kit for Monitoring Patients ... (Finanzen.net)
Immunicon Corporation (NASDAQ:IMMC) announced today that the FDA has cleared the CellSearch Circulating Tumor Cell (CTC) Kit as an aid in the monitoring of patients with metastatic prostate cancer. A sample of the patient s ...

Additional information in: FDA Approvals

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources

©2006 FDA-News.com. All rights reserved.

website free tracking